TenderDekho Logo
GEM

Bids are Invited For Nor Ethisterone 5 mg Tab,Oestrogen Conjugated 0 point 625 mg Tab,Gliclazide MR 30 mg Tab,Glipizide in JABALPUR, MADHYA PRADESH

Bid Publish Date

17-Mar-2025, 7:30 pm

Bid End Date

07-Apr-2025, 8:00 pm

EMD

₹290

Progress

RA
Issue17-Mar-2025, 7:30 pm
Reverse Auction05-Jun-2025, 10:00 am
AwardCompleted
Explore all 5 tabs to view complete tender details

Quantity

86520

Categories 29

A tender has been published for Indian Army Nor Ethisterone 5 mg Tab, Oestrogen Conjugated 0 point 625 mg Tab, Gliclazide MR 30 mg Tab, Glipizide 5 mg Tab, Pioglitazone Hydrochloride 15 mg Tab, Carbimazole 5 mg Tab, Tab Thyroxine Sodium 12 point 5 mcg, Cap Tacrolimus 1 mg prolonged release, Cap Tacrolimus 0 point 25 mg, Carnitine 200 mg Tab, Tacrolimus 0 point 5 mg Cap, Sevelamer 400 mg Tab, Sevelamer Carbonate Sachet 800 mg, Cinnarizine 25 mg Tab, Alprazolam 0 point 25 mg Tab, Chlorpromazine HCl 100 mg Tab, Chlorpromazine 25 mg Tab, Darifenacin 15 mg Tab, Solifenacin 10 mg Tab, Silodosin 4 mg Tab, Promethazine HCl 2 point 5 percent 25 mg ml 2 ml Inj, Tranexamic Acid 500 mg 5 ml Inj, Nandrolone Decanoate 25 mg ml Inj, Diltiazem 5 mg ml Inj, Labetalol HCl 5 mg ml 4 ml Inj, Atropine Sulphate 0 point 6 mg 1 ml Inj, Adrenaline Tartrate 1 each to 1000 1 ml Inj, Frusemide 20 mg 2 ml Inj, Inj Dexmedetomidine 100 mcg ml 50 ml vial, Ketamine HCl 50 mg ml 2 ml Inj, Thiopentone Inj of 0 point 5 g without water for Inj, Lignocaine Viscous 2 percent containing Lignocaine 21 point 3 mg Methyl, Lignocaine HCl 2 percent without Adrenaline 30 ml Inj suitable for ophthalmic, Inj Etomidate 2 mg ml 10 ml Vial, Lignocaine HCl 2 percent with Adrenaline 1 each to 80000 30 ml Inj, Inj Diclofenac 75 mg ml 1 ml Amp, Dexmedetomidine 100 mcg ml Inj, Paracetamol with Cysteine HCl monohydrate infusion 1000 mg 100 ml, Paracetamol 10 mg ml infusion in 50 ml bottle, Dexamethasone Sodium Phosphate 4 point 4 mg Equivalent to Dexamethasone, Pheniramine Maleate Inj 22 point 75 mg ml amp of 2 ml, Levetiracetam 100 mg ml Inj vial of 5 ml, Phenobarbitone Sodium 200 mg 1 ml Inj, Pneumococcal Conjugated polysaccharide vaccine 0 point 5 ml 13 Valent adsorbed, Verapamil 5 mg 2 ml Inj, Amiodarone HCl 150 mg 3 ml Inj, Esmolol 100 mg 10 ml Inj, Metoprolol 1 mg ml 5 ml Inj, Digoxin 0 point 5 mg 2 ml Inj, Vasopressin 20 units ml Inj 1 ml ampoule, Metoclopramide HCl 5 mg ml 2 ml Inj, Dicyclomine HCl 20 mg Inj, Carboprost Tromethamine 250 mcg ml 1 ml Inj, Hydroxyprogesterone Caproate 500 mg 2 ml Amp of 2 ml Inj, Methylergometrine maleate 0 point 2 mg 1 ml Inj, Oxytocin 5 units per 1 point 0 ml amp Inj, Glycopyrrolate 0 point 2 mg ml 1ml Inj, Neostigmine 0 point 5 mg 1 ml Inj, Succinylchloline Chloride 50 mg ml 2 ml Inj, Vecuronium Bromide 4 mg ml 1 ml Inj, Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj, Vit B1 50 mg Inj, Vit B 12 500 mcg ml Inj, Amoxycillin 250 mg plus Clavulanic Acid 50 mg 300 mg Inj, Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B 1 30 mg, Ciprofloxacin 200 mg 100 ml Inj, Levofloxacin 500 mg in 100 ml Inj, Hepatitis B Human Immunoglobulin HBIG, Human papilloma virus quadrivalent Types 6 11 16 18 vaccine Recombinant PFS of 0, Paracetamol 10 mg ml infusion in 100 ml bottle, Inj Ropivacaine 7 point 5 mg ml 10 ml Amp, Lignocaine HCl solution 2 percent for IV use 50 ml Inj, Inj mephentramine 30 mg ml of 10 ml each vial, Lignocaine 100 mg and Ethanol 28 percent v v spray container of 500 ml, Inj Naloxone 400 mcg ml of 1 ml amp, Inj Rocuronium 10 mg ml 10 ml Vial, Hydroxy Ethyl starch 6 percent soln bott of 500 ml, Human Rabies Immune Globulin 150 IU ml 2 ml Vial, Tetanus Toxoid purified absorbed rubber capped Vial of 5 ml 10 Doses, Phytomenadione Vit K 1 mg 0 point 5 ml Inj, Hepatitis B Vaccine 10 ml in JABALPUR, MADHYA PRADESH. Quantity: 86520 by. Submission Deadline: 07-04-2025 20: 00: 00. Check eligibility and apply.

Documents 4

GeM-Bidding-7604845.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

Acebrophylline 200 Mg Fexofenadine 120 Mg and Montelukast 10 Mg Tab,Acyclovir 400 Mg Tab,Azelnidipi

Dg Armed Forces Medical Service

Posted: 7 December 2024
Closed: 28 December 2024
GEM

Pomalidomide 2 Mg Tab,Hydroxyurea 500 mg Cap,Gefitinib 250mg Tab,Mercaptopurine 50mg Tab,Methotrexa

Indian Army

KANNUR, KERALA

Posted: 19 December 2025
Closed: 29 December 2025
GEM

Calcium Dobesilate 500 mg Capsules,Carbamazepine 100 Mg Tab,Cilnidipine 20 Mg Tab,Cinitapride 3Mg a

Dg Armed Forces Medical Service

KANNUR, KERALA

Posted: 23 May 2025
Closed: 13 June 2025
GEM

Isotretinoin 10 mg Tab,Isotretinoin 20 mg Tab,Itopride 150 mg Tab,Ivermectin 12mg Tab,L-Ornithine L

Indian Army

Posted: 22 September 2025
Closed: 3 October 2025
GEM

TACROLIMUS 0 point 5 MG TAB,SEVELAMER 400 MG TAB,MESALAMINE SUPPOSITORY,ACOTIAMIDE 100MG TAB,DOXYCY

Dg Armed Forces Medical Service

Posted: 6 December 2024
Closed: 28 December 2024
GEM

Bill of Quantities (BOQ) 81 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 Nor Ethisterone 5 mg Tab Nor Ethisterone 5 mg Tab 19,500 no dglpproc2023 30
2 Oestrogen Conjugated 0 point 625 mg Tab Oestrogen Conjugated 0 point 625 mg Tab 4,500 no dglpproc2023 30
3 Gliclazide MR 30 mg Tab Gliclazide MR 30 mg Tab 10,000 no dglpproc2023 30
4 Glipizide 5 mg Tab Glipizide 5 mg Tab 1,500 no dglpproc2023 30
5 Pioglitazone Hydrochloride 15 mg Tab Pioglitazone Hydrochloride 15 mg Tab 4,200 no dglpproc2023 30
6 Carbimazole 5 mg Tab Carbimazole 5 mg Tab 3,000 no dglpproc2023 30
7 Tab Thyroxine Sodium 12 point 5 mcg Tab Thyroxine Sodium 12 point 5 mcg 4,500 no dglpproc2023 30
8 Cap Tacrolimus 1 mg prolonged release Cap Tacrolimus 1 mg prolonged release 750 no dglpproc2023 30
9 Cap Tacrolimus 0 point 25 mg Cap Tacrolimus 0 point 25 mg 300 no dglpproc2023 30
10 Carnitine 200 mg Tab Carnitine 200 mg Tab 1,000 no dglpproc2023 30
11 Tacrolimus 0 point 5 mg Cap Tacrolimus 0 point 5 mg Cap 1,500 no dglpproc2023 30
12 Sevelamer 400 mg Tab Sevelamer 400 mg Tab 600 no dglpproc2023 30
13 Sevelamer Carbonate Sachet 800 mg Sevelamer Carbonate Sachet 800 mg 60 no dglpproc2023 30
14 Cinnarizine 25 mg Tab Cinnarizine 25 mg Tab 1,800 no dglpproc2023 30
15 Alprazolam 0 point 25 mg Tab Alprazolam 0 point 25 mg Tab 3,000 no dglpproc2023 30
16 Chlorpromazine HCl 100 mg Tab Chlorpromazine HCl 100 mg Tab 600 no dglpproc2023 30
17 Chlorpromazine 25 mg Tab Chlorpromazine 25 mg Tab 600 no dglpproc2023 30
18 Darifenacin 15 mg Tab Darifenacin 15 mg Tab 330 no dglpproc2023 30
19 Solifenacin 10 mg Tab Solifenacin 10 mg Tab 180 no dglpproc2023 30
20 Silodosin 4 mg Tab Silodosin 4 mg Tab 750 no dglpproc2023 30
21 Promethazine HCl 2 point 5 percent 25 mg ml 2 ml Inj Promethazine HCl 2 point 5 percent 25 mg ml 2 ml Inj 600 amp dglpproc2023 30
22 Tranexamic Acid 500 mg 5 ml Inj Tranexamic Acid 500 mg 5 ml Inj 1,650 amp dglpproc2023 30
23 Nandrolone Decanoate 25 mg ml Inj Nandrolone Decanoate 25 mg ml Inj 30 amp dglpproc2023 30
24 Diltiazem 5 mg ml Inj Diltiazem 5 mg ml Inj 30 amp dglpproc2023 30
25 Labetalol HCl 5 mg ml 4 ml Inj Labetalol HCl 5 mg ml 4 ml Inj 300 amp dglpproc2023 30
26 Atropine Sulphate 0 point 6 mg 1 ml Inj Atropine Sulphate 0 point 6 mg 1 ml Inj 750 amp dglpproc2023 30
27 Adrenaline Tartrate 1 each to 1000 1 ml Inj Adrenaline Tartrate 1 each to 1000 1 ml Inj 1,350 amp dglpproc2023 30
28 Frusemide 20 mg 2 ml Inj Frusemide 20 mg 2 ml Inj 1,200 amp dglpproc2023 30
29 Inj Dexmedetomidine 100 mcg ml 50 ml vial Inj Dexmedetomidine 100 mcg ml 50 ml vial 90 amp vial dglpproc2023 30
30 Ketamine HCl 50 mg ml 2 ml Inj Ketamine HCl 50 mg ml 2 ml Inj 120 vial dglpproc2023 30
31 Thiopentone Inj of 0 point 5 g without water for Inj Thiopentone Inj of 0 point 5 g without water for Inj 30 vial dglpproc2023 30
32 Lignocaine Viscous 2 percent containing Lignocaine 21 point 3 mg Methyl Lignocaine Viscous 2 percent containing Lignocaine 21 point 3 mg Methyl 45 bott dglpproc2023 30
33 Lignocaine HCl 2 percent without Adrenaline 30 ml Inj suitable for ophthalmic Lignocaine HCl 2 percent without Adrenaline 30 ml Inj suitable for ophthalmic 200 amp dglpproc2023 30
34 Inj Etomidate 2 mg ml 10 ml Vial Inj Etomidate 2 mg ml 10 ml Vial 30 vial dglpproc2023 30
35 Lignocaine HCl 2 percent with Adrenaline 1 each to 80000 30 ml Inj Lignocaine HCl 2 percent with Adrenaline 1 each to 80000 30 ml Inj 210 vial dglpproc2023 30
36 Inj Diclofenac 75 mg ml 1 ml Amp Inj Diclofenac 75 mg ml 1 ml Amp 800 vial dglpproc2023 30
37 Dexmedetomidine 100 mcg ml Inj Dexmedetomidine 100 mcg ml Inj 210 amp dglpproc2023 30
38 Paracetamol with Cysteine HCl monohydrate infusion 1000 mg 100 ml Paracetamol with Cysteine HCl monohydrate infusion 1000 mg 100 ml 900 bott dglpproc2023 30
39 Paracetamol 10 mg ml infusion in 50 ml bottle Paracetamol 10 mg ml infusion in 50 ml bottle 1,500 bott dglpproc2023 30
40 Dexamethasone Sodium Phosphate 4 point 4 mg Equivalent to Dexamethasone Dexamethasone Sodium Phosphate 4 point 4 mg Equivalent to Dexamethasone 300 vial dglpproc2023 30
41 Pheniramine Maleate Inj 22 point 75 mg ml amp of 2 ml Pheniramine Maleate Inj 22 point 75 mg ml amp of 2 ml 350 vial dglpproc2023 30
42 Levetiracetam 100 mg ml Inj vial of 5 ml Levetiracetam 100 mg ml Inj vial of 5 ml 200 vial dglpproc2023 30
43 Phenobarbitone Sodium 200 mg 1 ml Inj Phenobarbitone Sodium 200 mg 1 ml Inj 50 vial dglpproc2023 30
44 Pneumococcal Conjugated polysaccharide vaccine 0 point 5 ml 13 Valent adsorbed Pneumococcal Conjugated polysaccharide vaccine 0 point 5 ml 13 Valent adsorbed 20 pfs dglpproc2023 30
45 Verapamil 5 mg 2 ml Inj Verapamil 5 mg 2 ml Inj 30 vial dglpproc2023 30
46 Amiodarone HCl 150 mg 3 ml Inj Amiodarone HCl 150 mg 3 ml Inj 75 vial dglpproc2023 30
47 Esmolol 100 mg 10 ml Inj Esmolol 100 mg 10 ml Inj 30 vial dglpproc2023 30
48 Metoprolol 1 mg ml 5 ml Inj Metoprolol 1 mg ml 5 ml Inj 75 vial dglpproc2023 30
49 Digoxin 0 point 5 mg 2 ml Inj Digoxin 0 point 5 mg 2 ml Inj 45 vial dglpproc2023 30
50 Vasopressin 20 units ml Inj 1 ml ampoule Vasopressin 20 units ml Inj 1 ml ampoule 125 vial dglpproc2023 30
51 Metoclopramide HCl 5 mg ml 2 ml Inj Metoclopramide HCl 5 mg ml 2 ml Inj 800 vial dglpproc2023 30
52 Dicyclomine HCl 20 mg Inj Dicyclomine HCl 20 mg Inj 600 vial dglpproc2023 30
53 Carboprost Tromethamine 250 mcg ml 1 ml Inj Carboprost Tromethamine 250 mcg ml 1 ml Inj 228 vial dglpproc2023 30
54 Hydroxyprogesterone Caproate 500 mg 2 ml Amp of 2 ml Inj Hydroxyprogesterone Caproate 500 mg 2 ml Amp of 2 ml Inj 300 vial dglpproc2023 30
55 Methylergometrine maleate 0 point 2 mg 1 ml Inj Methylergometrine maleate 0 point 2 mg 1 ml Inj 300 vial dglpproc2023 30
56 Oxytocin 5 units per 1 point 0 ml amp Inj Oxytocin 5 units per 1 point 0 ml amp Inj 1,500 vial dglpproc2023 30
57 Glycopyrrolate 0 point 2 mg ml 1ml Inj Glycopyrrolate 0 point 2 mg ml 1ml Inj 420 vial dglpproc2023 30
58 Neostigmine 0 point 5 mg 1 ml Inj Neostigmine 0 point 5 mg 1 ml Inj 390 vial dglpproc2023 30
59 Succinylchloline Chloride 50 mg ml 2 ml Inj Succinylchloline Chloride 50 mg ml 2 ml Inj 30 vial dglpproc2023 30
60 Vecuronium Bromide 4 mg ml 1 ml Inj Vecuronium Bromide 4 mg ml 1 ml Inj 150 vial dglpproc2023 30
61 Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj Etophylline BP 84 point 7 mg and Theophylline IP 25 point 3 mg per ml 2 ml Inj 300 vial dglpproc2023 30
62 Vit B1 50 mg Inj Vit B1 50 mg Inj 500 vial dglpproc2023 30
63 Vit B 12 500 mcg ml Inj Vit B 12 500 mcg ml Inj 1,000 vial dglpproc2023 30
64 Amoxycillin 250 mg plus Clavulanic Acid 50 mg 300 mg Inj Amoxycillin 250 mg plus Clavulanic Acid 50 mg 300 mg Inj 250 vial dglpproc2023 30
65 Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B 1 30 mg Multi Vit Inj IV 2 10 ml with minimum constituents having Thiamine B 1 30 mg 1,200 vial dglpproc2023 30
66 Ciprofloxacin 200 mg 100 ml Inj Ciprofloxacin 200 mg 100 ml Inj 1,500 amp vial dglpproc2023 30
67 Levofloxacin 500 mg in 100 ml Inj Levofloxacin 500 mg in 100 ml Inj 450 bott dglpproc2023 30
68 Hepatitis B Human Immunoglobulin HBIG Hepatitis B Human Immunoglobulin HBIG 6 amp dglpproc2023 30
69 Human papilloma virus quadrivalent Types 6 11 16 18 vaccine Recombinant PFS of 0 Human papilloma virus quadrivalent Types 6 11 16 18 vaccine Recombinant PFS of 0 150 pfs dglpproc2023 30
70 Paracetamol 10 mg ml infusion in 100 ml bottle Paracetamol 10 mg ml infusion in 100 ml bottle 3,600 bott dglpproc2023 30
71 Inj Ropivacaine 7 point 5 mg ml 10 ml Amp Inj Ropivacaine 7 point 5 mg ml 10 ml Amp 30 amp dglpproc2023 30
72 Lignocaine HCl solution 2 percent for IV use 50 ml Inj Lignocaine HCl solution 2 percent for IV use 50 ml Inj 25 amp vial dglpproc2023 30
73 Inj mephentramine 30 mg ml of 10 ml each vial Inj mephentramine 30 mg ml of 10 ml each vial 15 vial dglpproc2023 30
74 Lignocaine 100 mg and Ethanol 28 percent v v spray container of 500 ml Lignocaine 100 mg and Ethanol 28 percent v v spray container of 500 ml 12 no dglpproc2023 30
75 Inj Naloxone 400 mcg ml of 1 ml amp Inj Naloxone 400 mcg ml of 1 ml amp 15 amp dglpproc2023 30
76 Inj Rocuronium 10 mg ml 10 ml Vial Inj Rocuronium 10 mg ml 10 ml Vial 10 vial dglpproc2023 30
77 Hydroxy Ethyl starch 6 percent soln bott of 500 ml Hydroxy Ethyl starch 6 percent soln bott of 500 ml 14 bott dglpproc2023 30
78 Human Rabies Immune Globulin 150 IU ml 2 ml Vial Human Rabies Immune Globulin 150 IU ml 2 ml Vial 10 vial dglpproc2023 30
79 Tetanus Toxoid purified absorbed rubber capped Vial of 5 ml 10 Doses Tetanus Toxoid purified absorbed rubber capped Vial of 5 ml 10 Doses 900 amp vial dglpproc2023 30
80 Phytomenadione Vit K 1 mg 0 point 5 ml Inj Phytomenadione Vit K 1 mg 0 point 5 ml Inj 900 amp vial dglpproc2023 30
81 Hepatitis B Vaccine 10 ml Hepatitis B Vaccine 10 ml 900 amp vial dglpproc2023 30

Reverse Auction Schedule

Completed

Start

05-Jun-2025, 10:00 am

End

09-Jun-2025, 5:00 pm

Duration: 103 hours

Reverse Auction Document

✅ RA concluded. Check financial results for final rankings.

Technical Results

S.No Seller Item Date Status
1**********   Under PMA-03-04-2025 15:57:58Evaluated
2**********   Under PMA-28-03-2025 16:35:50Evaluated
3**********   Under PMA-02-04-2025 12:58:51Evaluated
4**********   Under PMA-05-04-2025 15:45:45Evaluated
5**********   Under PMA-07-04-2025 19:29:45Evaluated
6**********   Under PMA-07-04-2025 18:41:29Evaluated
7**********   Under PMA-02-04-2025 19:15:32Evaluated
8**********   Under PMA-20-03-2025 17:57:47Evaluated
9**********   Under PMA-26-03-2025 11:05:35Evaluated
10**********   Under PMA-20-03-2025 10:42:50Evaluated
11**********   Under PMA-07-04-2025 18:35:30Evaluated
12**********   Under PMA-07-04-2025 16:32:41Evaluated
13**********   Under PMA-21-03-2025 16:40:27Evaluated
14**********   Under PMA-07-04-2025 17:59:07Evaluated
15**********   Under PMA-27-03-2025 17:28:19Evaluated
16**********   Under PMA-07-04-2025 19:50:44Evaluated
17**********   Under PMA-07-04-2025 16:09:47Evaluated

Frequently Asked Questions

Key insights about MADHYA PRADESH tender market

What are the eligibility requirements for GEM/2025/B/6022321?

The eligibility requirements include being a registered entity, adherence to pharmaceutical industry regulations, and relevant experience in supplying medicine. Bidders must comply with the necessary documentation and eligibility criteria to ensure their participation.

What technical specifications must suppliers adhere to in the General Medicine tender?

Suppliers must ensure that all products meet stringent technical specifications and quality standards. This includes providing medications with appropriate certifications, following storage and transportation standards, and confirming compliance with pharmaceutical safety regulations.

What are the payment terms for the GEM/2025/B/6022321 tender?

Payment terms typically involve detailed conditions outlined in the tender documentation. Bidders should be prepared to meet specific financial requirements and provide clarity regarding their pricing strategy, ensuring transparency in the price evaluation considerations during the procurement process.

How should submissions be made for the General Medicine tender?

Submissions should be made electronically or physically according to the guidelines issued in the tender documentation. It’s imperative that all required documents are included and submitted in the accepted formats to facilitate a smooth evaluation and selection process.

What benefits do Micro, Small, and Medium Enterprises (MSEs) receive in this tender?

The tender outlines specific benefits for Micro, Small, and Medium Enterprises (MSEs) to encourage their participation. Provisions may include relaxed eligibility criteria, assistance in the registration process, and potential price preferences, ultimately supporting local businesses and startups in the pharmaceutical sector.

These FAQs encompass critical aspects of the tender, providing clarity and guidance for prospective bidders. Interested parties are encouraged to thoroughly analyze the criteria and prepare their submissions accordingly.